Description
Are you ready to save a day a week? Make meetings matter again. This book could be the best investment in your productivity and engagement that you ever make.Meetings are probably the largest unmanaged cost area in large organizations. Today meetings consume about 40% of working time for managers and professionals (our most senior and expensive people). People are frustrated with too many boring, irrelevant or badly run meetings. Research shows that managerial and professional people on average spend two days per week in meetings. For business, this is a huge cost.Kill Bad Meetings will show you how to cut out the unnecessary meetings, topics and participants that make many meetings irrelevant. Unlike other books looking at improving the effectiveness of meetings, this book starts with cancelling meetings altogether. Kill Bad Meetings will show you how to save yourself several hours of time a week-so you can move on to focus on improving the planning and running of the remaining 50% of meetings that actually do need to happen.
Author: Kevan Hall
Publisher: Nicholas Brealey Publishing
Published: 11/14/2023
Pages: 224
Binding Type: Paperback
Weight: 0.44lbs
Size: 8.40h x 5.30w x 0.80d
ISBN13: 9781399810913
ISBN10: 139981091X
BISAC Categories:
- Business & Economics | Business Communication | Meetings & Presentations
- Business & Economics | Leadership
- Business & Economics | Workplace Culture
Author: Kevan Hall
Publisher: Nicholas Brealey Publishing
Published: 11/14/2023
Pages: 224
Binding Type: Paperback
Weight: 0.44lbs
Size: 8.40h x 5.30w x 0.80d
ISBN13: 9781399810913
ISBN10: 139981091X
BISAC Categories:
- Business & Economics | Business Communication | Meetings & Presentations
- Business & Economics | Leadership
- Business & Economics | Workplace Culture
About the Author
Kevan Hall is the founder and CEO of Global Integration Ltd., a consultancy specializing in skills required to work in complex, international organizations, with offices in the UK and California. He works with companies around the world including Microsoft, Coca-Cola, GlaxoSmithKline, and Vodafone.

